Added to YB: 2019-03-26
Pitch date: 2019-03-26
NERV [bullish]
Minerva Neurosciences, Inc.
-93.86%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
Market Cap
$9.6M
Pitch Price
$63.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.21
P/E
7.21
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
MINERVA NEUROSCIENCES INC NERV
A summary for this pitch has not been created yet.
Read full article (0 min)